Você procurou por: becaplermin (Inglês - Letão)

becaplermin
becaplerminum

regranex becaplermin
regranex bekaplermīns

regranex 0.01% gel becaplermin
regranex 0,01% gels becaplerminum

100 microgram / g gel becaplermin
100 mikorgrami bekaplermīna / g gela

it contains a substance called becaplermin.
tās satur aktīvo vielu, ko sauc par bekaplermīnu.

each gram of gel contains 100 g of becaplermin
viens grams gela satur 100 g bekaplermīna.

the active substance in regranex is becaplermin.
regranex aktīvā viela ir bekaplermīns.

each gram of gel contains 100 g of becaplermin*.
viens grams gela satur 100 g bekaplermīna* (becaplerminum).

each gram of regranex contains 100 micrograms of becaplermin.
katrs regranex grams satur 100 mikrogramus bekaplermīna.

regranex is a gel that contains the active substance becaplermin.
regranex ir zāles, kas satur aktīvo vielu bekaplermīnu.

it is not known whether becaplermin is excreted in human milk.
nav zināms, vai bekaplermīns izdalās ar mātes pienu.

in the process of healing the wound, becaplermin induces cell proliferation.
brūces dzīšanas procesā bekaplermīns inducē šūnu proliferāciju.

becaplermin was not mutagenic in a battery of in vitro and in vivo tests.
bekaplermīns neuzrādīja mutagēnu iedarbību virknē in vitro un in vivo pētījumu.

becaplermin is a human recombinant platelet derived growth factor (rhpdgf).
bekaplermīns ir rekombinants cilvēka trombocītu augšanas faktors (rhpdgf).

the biological activity of becaplermin includes promoting the chemotactic recruitment and proliferation of cells involved in wound repair.
bekaplermīna bioloģiskā aktivitāte saistīta ar šūnu, kas piedalās brūces dzīšanā, proliferācijas un hemotakses veicināšanu.

malignancies distant from the site of application have occurred in becaplermin users in both clinical trial and in post-marketing use.
bekaplermīna lietotājiem gan klīnisko pētījumu, gan pēcreģistrācijas perioda laikā ir radušies no lietošanas vietas attāli ļaundabīgi audzēji.

becaplermin is produced by insertion of the gene for the b chain of human platelet derived growth factor into the yeast, saccharomyces cerevisiae.
bekaplermīnu iegūst, ievietojot cilvēka trombocītu augšanas faktora b ķēdes gēnu rauga sēnītē saccharomyces cerevisiae.

regranex should not be used in people who may be hypersensitive (allergic) to becaplermin or any of the other ingredients.
regranex nedrīkst lietot cilvēki ar paaugstinātu jutību (alerģiju) pret bekaplermīnu vai kādu citu šo zāļu sastāvdaļu.

regranex is a clear colourless to straw-coloured gel, which contains 0.01% of the active substance becaplermin.
regranex ir dzidra, bezkrāsas vai salmu krāsas želeja, kas satur 0, 01% aktīvās vielas bekaplermīna.

regranex contains becaplermin, a recombinant human platelet derived growth factor-bb (rhpdgf-bb).
regranex satur bekaplermīnu, rekombinantu cilvēka trombocītu augšanas faktoru-bb (rhpdgf- bb- recombinant human platelet derived growth factor –bb).